As of 2025, coverage for GLP-1s under Medicare Part D is widespread for type 2 diabetes but negligible for obesity or other non-diabetes indications (for example, only 1% coverage for semaglutide for cardiovascular disease, and zero coverage for tirzepatide for obstructive sleep apnea)
According to the FDAs 2023 guidance, Ipamorelin is currently not eligible for compounding under Section 503A and is classified as a Category B bulk drug substance due to a lack of safety data
Aside from being an antioxidant powerhouse, glutathione is also helpful for detoxification, immune support, and maintaining healthy aging
When it comes to autism spectrum disorder and other neurodevelopmental disorder issues, this imbalance has been identified as a major contributor, especially in children diagnosed with these conditions
Patients may therefore be given different products, according to what is available at their local pharmacies, with the prescriber generally unaware of the specific product that the patient is taking at any particular time